00775

0.4902.00%
YC

Ying Choi Yu

CEO & Executive Deputy Chairman

Mr. Ying Choi Yu, also known as Alan Abel, serves as Chief Executive Officer at CK Life Sciences Int'l., (Holdings) Inc. since May 08, 2026 and was its Chief Executive Officer since September 1, 2020 until September 20, 2024 and served as its Vice President until September 20, 2024. He serves as Deputy Chairman at CK Life Sciences Int'l., (Holdings) Inc. from September 20, 2024 and serves as its Executive Director. He serves as a Director of Dogwood Therapeutics, Inc. (formerly known as Virios Therapeutics, Inc.) since October 7, 2024. He served as Chief Operating Officer of CK Life Sciences Int'l., (Holdings) Inc. until September 1, 2020 and its Compliance Officer since November 16, 2005. Mr. Yu is responsible for the commercial activities including manufacturing and marketing of all product applications at CK Life Sciences. He has held a number of positions in multinational corporations, including Standard Chartered Bank, Dairy Farm and American Express, in Hong Kong and overseas. Prior to joining CK Life Sciences International Holdings Inc. in January 2000, he served as a Worldwide Vice President with Johnson & Johnson. He holds Bachelor of Arts degree and a Master's degree in Business Administration.

Positions